NASDAQ | ETF
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio ofU. S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than 250 million.
The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index.
Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.27% |
| NK | NantKwest Inc | Healthcare | Biotechnology | 2.17% |
| GLUE | Monte Rosa Therapeutics Inc | Healthcare | Biotechnology | 2.03% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.90% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.84% |
| ZA8 | ZYMEWORKS DL-00001 | Healthcare | Biotechnology | 1.80% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 1.78% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.76% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.73% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.72% |
| ELVN | Enliven Therapeutics Inc. | Healthcare | Biotechnology | 1.68% |
| XNCR | Xencor Inc | Healthcare | Biotechnology | 1.66% |
| MRSN | Mersana Therapeutics Inc | Healthcare | Biotechnology | 1.62% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.58% |
| KPTI | Karyopharm Therapeutics Inc | Healthcare | Biotechnology | 1.57% |
| GNLX | Genelux Corporation Common Stock | Healthcare | Biotechnology | 1.56% |
| REPL | Replimune Group Inc | Healthcare | Biotechnology | 1.56% |
| MGNX | MacroGenics Inc | Healthcare | Biotechnology | 1.55% |
| HCM | HUTCHMED DRC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.54% |
| RAIN | Rain Therapeutics Inc | Healthcare | Biotechnology | 1.52% |